Metformin in Step-down Regimen Versus Conventional Low Dose Step-up Protocol in Patients With PCOS Undergoing IVF
Launched by UNIVERSITY OF MODENA AND REGGIO EMILIA · Sep 20, 2011
Trial Information
Current as of May 07, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • PCOS
- • Infertility
- • High responders
- Exclusion Criteria:
- • Poor responders
- • Major medical conditions
About University Of Modena And Reggio Emilia
The University of Modena and Reggio Emilia, a prestigious institution located in Italy, is renowned for its commitment to advancing medical research and education. With a strong focus on innovation and interdisciplinary collaboration, the university plays a pivotal role in conducting clinical trials that aim to improve healthcare outcomes. Its dedicated team of researchers and clinicians are engaged in cutting-edge studies across various medical fields, fostering an environment that encourages scientific inquiry and the translation of research findings into clinical practice. The university's robust infrastructure and emphasis on ethical standards ensure the integrity and reliability of its clinical trials, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Catanzaro, , Italy
Patients applied
Trial Officials
Stefano Palomba, MD
Principal Investigator
Department of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials